Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Apellis Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
APLS
Nasdaq
8731
https://apellis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
- Apr 23rd, 2024 11:00 am
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 4th, 2024 8:05 pm
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 1st, 2024 11:00 am
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
- Mar 28th, 2024 3:30 pm
Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
- Mar 19th, 2024 11:01 pm
30 Biggest Biotechnology Companies in the World
- Mar 17th, 2024 12:50 pm
Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
- Mar 14th, 2024 11:02 pm
Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
- Mar 11th, 2024 11:02 pm
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
- Mar 11th, 2024 11:00 am
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:35 pm
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
- Feb 28th, 2024 2:07 pm
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 27th, 2024 2:30 pm
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
- Feb 27th, 2024 2:11 pm
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates
- Feb 27th, 2024 1:20 pm
Apellis Pharmaceuticals Inc (APLS) Reports Robust Revenue Growth in 2023
- Feb 27th, 2024 12:51 pm
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 27th, 2024 12:05 pm
5 Stocks to Buy That Are Poised to Beat on Earnings This Week
- Feb 26th, 2024 12:38 pm
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
- Feb 26th, 2024 12:00 pm
Why Apellis (APLS) Might Surprise This Earnings Season
- Feb 23rd, 2024 2:27 pm
Apellis Pharmaceuticals, Inc. (APLS) Upgraded to Buy: Here's What You Should Know
- Feb 20th, 2024 5:00 pm
Scroll